Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Neumedicines Logo
Neumedicines CB Rank
951139
Heat Score
51
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
Founded
obfuscation
Private Pasadena, California, United States11-50 www.neumedicines.com
Biotechnology
Therapeutics
Overview

Neumedicines
Heat Score
51

Growth Score
pts
in past quarter
Heat Score 51
-17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Neumedicines

CB Rank
951139
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
Founded
obfuscation
Private Pasadena, California, United States11-50 www.neumedicines.com
Biotechnology
Therapeutics

Key People

Details

Operating Status Active
Company Type For Profit
About the Company
Privately held biotechnology company developing protein therapeutics that address unmet clinical and societal needs in the areas of Oncology, Hematology and Immunology
Phone Number 6268443810
Contact Email info@neumedicines.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

HemaMax
A recombinant human interleukin-12 (rHuIL-12) used as an immunotherapeutic agent for cancer treatment and as a monotherapy for Hematopoietic Syndrome of Acute Radiation Syndrome (HSARS).

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$81.8KThis year, Neumedicines is projected to spend $81.8K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Getty Images Logo
Getty Images
97
Content Threat Removal Logo
Content Threat Removal
95
Group Calendars Logo
Group Calendars
93

Actively Used Products

3Neumedicines uses 3 technology products and services including HTML5, Vimeo, and  Google Fonts, according to G2 Stack.

Active Website Tech Count

3Neumedicines is actively using 3 technologies for its website, according to BuiltWith. These include Viewport Meta, Common Crawl, and  CommonCrawl Top 50m.

Total IP

13The intellectual property of Neumedicines includes 13 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Neumedicines's headquarters? Neumedicines is located in Pasadena, California, United States.Who are Neumedicines's competitors? Alternatives and possible competitors to Neumedicines may include Bristol-Myers Squibb, Ligand Pharmaceuticals, and  Partner Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|